Skip to main content
Caplight Logo









Lucis

Lucis

Private
ParisHealthcare & Life Scienceshttps://www.lucis.life/

Last Round

Series A

May 26, 2026

Est. Valuation

$1.79M

Total Funding Raised

$29M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Lucis is a European preventative health-tech company that provides an AI-powered platform to transform blood test results into personalized health insights and actionable recommendations.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement

Business Model

B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

preventive health platformbiomarker trackingdigital healthteleconsultationhealth techlongevitypersonalized healthcontinuous glucose monitoringCGMhealth analyticspatient engagementbiohackingsubscription SaaSpreventive medicinehealth companion app

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lucis Comparables

Compare Lucis with similar companies based on industry and business-model similarity.

Lucis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zoï
80%
Qura
78%
Emerald
75%

Lucis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 26, 2026
SeedDec 16, 2025
AcceleratorJun 9, 2025

Key People

Founding team and executive leadership

Baptiste Debever

Co-Founder CTO

Founding Team

Lucis Investors

Notable investors and investment history

Lucis investors
InvestorRounds
Kima VenturesSeed, Accelerator
LongGame VenturesAccelerator
Circle & CoSeed
SingularSeries A
General CatalystSeries A, Seed
Motier VenturesSeed
Y CombinatorSeed, Accelerator, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 17, 2026

    Open roles increased to 10, 3.5x the trailing average.

  • Aug 1, 2026

    Open roles increased to 8, representing 29% of headcount.

Lucis Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lucis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lucis's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range28
Year Founded2025
Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?